Feinstein researchers identify intelligence gene
GLEN OAKS, NY -- Psychiatric researchers at The Zucker Hillside Hospital
campus of The Feinstein Institute for Medical Research have uncovered
evidence of a gene that appears to influence intelligence. Working in
conjunction with researchers at Harvard Partners Center for Genetics and
Genomics in Boston, the Zucker Hillside team examined the genetic
blueprints of individuals with schizophrenia, a neuropsychiatric disorder
characterized by cognitive impairment, and compared them with healthy
volunteers. They discovered that the dysbindin-1 gene (DTNBP1), which they
previously demonstrated to be associated with schizophrenia, may also be
linked to general cognitive ability. The study is published in the May 15
print issue of Human Molecular Genetics, available online today, April 27.
"A robust body of evidence suggests that cognitive abilities, particularly
intelligence, are significantly influenced by genetic factors. Existing
data already suggests that dysbindin may influence cognition," said
Katherine Burdick, PhD, the study's primary author. "We looked at several
DNA sequence variations within the dysbindin gene and found one of them to
be significantly associated with lower general cognitive ability in
carriers of the risk variant compared with non-carriers in two independent
groups."
The study involved 213 unrelated Caucasian patients with schizophrenia or
schizoaffective disorder and 126 unrelated healthy Caucasian volunteers.
The researchers measured cognitive performance in all subjects. They then
analyzed participants' DNA samples. The researchers specifically examined
six DNA sequence variations, also known as single nucleotide polymorphisms
(SNPs), in the dysbindin gene and found that one specific pattern of SNPs,
known as a haplotype, was associated with general cognitive ability:
Cognition was significantly impaired in carriers of the risk variant in
both the schizophrenia group and the healthy volunteers as compared with
the non-carriers.
eurekalert.org
Nootrópicos (smartdrugs, drogas inteligentes, potenciadores cognitivos) son sustancias artificiales (medicamentos como piracetam, hydergina, citicolina, fosfatidilserina, vinpocetina, etc.) o naturales (suplementos nutricionales, vitaminas, aminoácidos, hormonas, hierbas, etc. como vitaminas B, piroglutamato, Gingko Biloba, fenilalanina, DHEA, pregnenolona, etc.) que se utilizan para mejorar la capacidad cognitiva (memoria, atención, etc.) en personas con trastornos o normales.
